Edition:
United Kingdom

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

161.01USD
22 Jan 2019
Change (% chg)

$-2.16 (-1.32%)
Prev Close
$163.17
Open
$163.17
Day's High
$163.74
Day's Low
$160.13
Volume
91,865
Avg. Vol
107,628
52-wk High
$205.99
52-wk Low
$128.12

Latest Key Developments (Source: Significant Developments)

Bio-Techne Releases First Quarter Fiscal 2019 Results
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Bio-Techne Corp ::BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2019 RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.98.Q1 GAAP EARNINGS PER SHARE $0.45.Q1 SALES $163 MILLION VERSUS I/B/E/S VIEW $161.9 MILLION.Q1 EARNINGS PER SHARE VIEW $0.95 -- THOMSON REUTERS I/B/E/S.  Full Article

Bio-Techne Signs Strategic Co-operation Agreement
Friday, 12 Oct 2018 

Oct 12 (Reuters) - Bio-Techne Corp ::BIO-TECHNE SIGNS STRATEGIC COOPERATION AGREEMENT WITH MICROPOINT BIOSCIENCE.BIO-TECHNE - CO, MICROPOINT BIOSCIENCE WILL FURTHER STRENGTHEN INTEGRATION OF MICROPOINT'S MICROFLUIDIC DIAGNOSTIC CHIP FOR POINT-OF-CARE TESTING.  Full Article

Bio-Techne Corp Completed Acquisition Of Exosome Diagnostics
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Bio-Techne Corp ::BIO-TECHNE CORPORATION COMPLETED ITS ACQUISITION OF EXOSOME DIAGNOSTICS, INC..  Full Article

Bio-Techne To Acquire Exosome Diagnostics Inc
Monday, 25 Jun 2018 

June 25 (Reuters) - Bio-Techne Corp ::BIO-TECHNE TO ACQUIRE EXOSOME DIAGNOSTICS, INC..BIO-TECHNE CORP - DEAL FOR $250 MILLION IN CASH PLUS CONTINGENT CONSIDERATION OF UP TO $325 MILLION DUE UPON ACHIEVEMENT OF CERTAIN FUTURE MILESTONES.BIO-TECHNE CORP - DEAL TO BE FINANCED USING CASH ON HAND & A REVOLVING LINE OF CREDIT FACILITY THAT CO EXPECTS TO OBTAIN PRIOR TO CLOSING OF DEAL.  Full Article

Bio-Techne Acquires Atlanta Biologicals Inc
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Bio-Techne Corp ::BIO-TECHNE ACQUIRES ATLANTA BIOLOGICALS INC.BIO-TECHNE CORP - ‍TRANSACTION IS FINANCED THROUGH AVAILABLE CASH ON HAND​.BIO-TECHNE - DEAL EXPECTED TO BE SLIGHTLY ACCRETIVE TO ADJUSTED EARNINGS PER SHARE FOR FISCAL YEAR 2018.  Full Article

Bio-Techne releases Q1 adjusted earnings per share $0.90
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Bio-Techne Corp :Bio-Techne releases first quarter fiscal 2018 results.Q1 adjusted earnings per share $0.90.Q1 GAAP earnings per share $0.42.Q1 sales $144.6 million versus I/B/E/S view $142.9 million.Q1 earnings per share view $0.88 -- Thomson Reuters I/B/E/S.  Full Article